Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 10-2007 | 07-2007 | 04-2007 | 01-2007 | 10-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,560 | N/A | -6,727 | -4,685 | -1,122 |
| Depreciation Amortization | 18 | N/A | 68 | 45 | 20 |
| Accounts receivable | 294 | N/A | 1,872 | 2,420 | 143 |
| Other Working Capital | 231 | N/A | 2,933 | 4,070 | 574 |
| Other Operating Activity | 95 | 0 | -923 | -2,185 | -24 |
| Operating Cash Flow | $-1,922 | $N/A | $-2,776 | $-334 | $-410 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 442 | N/A | N/A | N/A | N/A |
| PPE Investments | -22 | N/A | -224 | -215 | -180 |
| Purchase Of Investment | N/A | N/A | -750 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -2,500 | 0 |
| Investing Cash Flow | $420 | $N/A | $-974 | $-2,715 | $-180 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 78 | 20 | N/A |
| Financing Cash Flow | $N/A | $N/A | $78 | $20 | $N/A |
| Beginning Cash Position | 6,572 | N/A | 12,909 | 12,909 | 12,909 |
| End Cash Position | 5,070 | N/A | 9,239 | 9,880 | 12,319 |
| Net Cash Flow | $-1,502 | $N/A | $-3,671 | $-3,030 | $-590 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,922 | N/A | -2,776 | -334 | -410 |
| Capital Expenditure | -22 | N/A | -224 | -215 | -180 |
| Free Cash Flow | -1,944 | 0 | -2,999 | -549 | -590 |